All In Biotech

Drug Trial Radar · NCT04101578

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Prospective Observational Trial to Evaluate Clinical Prognosis and the Risk Factors for Progression for Myasthenia Gravis Patients

Last checked: Nov 20, 2026Latest source record: Aug 23, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

2,000

Planned (sponsor's estimate)

Start

Feb 8, 2017

Primary completion

Jun 1, 2023

Study completion Dec 31, 2024

Sponsor

Lead sponsor
Da, Yuwei, M.D.Individual
Sponsor type
Individual
First posted
Sep 24, 2019

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study collects the clinical data of myasthenia gravis (MG) patients, assesses outcomes and adverse effects of different treatment regimens, and searches for risk factors of conversion to generalized MG.

Conditions

  • Myasthenia Gravis

Interventions

  • Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)Drug

    Treatment regimens are determined according to the physician's judgment and preferences of the patients.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Conversion rates from ocular to generalized MG at the last visit and risk factors.Time frame: Baseline, 48 months
  2. Change in Quantitative Myasthenia Gravis (QMG) Scores from Baseline to 48 months.Time frame: Baseline, 12 months, 24 months, 36 months, 48 months
  3. Change in MG-specific Activities of Daily Living scale (MG-ADL).Time frame: Baseline,3months, 6 months, 9 months, 12 months, 18 months, 24 months, 30months, 36 months, 42 months, 48 months
  4. The proportion of patients reaching minimal manifestations (MM) or better.Time frame: 48 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Xuan Wu Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.